Evidence map›Paper›PMID 35444000›Full record

Observational studyEuropean journal of hospital pharmacy : science and practice2023

Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results.

Mayte Gil-Candel, Antonio Solana-Altabella, Esther Vicente-Escrig, Aarón Puplá-Bartoll, Julia Bodega Azuara, Pablo Pérez-Huertas, Raul Ferrando Piqueres

Abstract readObservational Study
In one paragraph

Observational study in European journal of hospital pharmacy : science and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mayte Gil-CandelPharmacy, Hospital General Universitari de Castelló, Castellón de la Plana, Comunidad Valenciana, Spain maigc29@gmail.com.ORCID 0000-0002-7398-8350
Antonio Solana-AltabellaPharmacy, Hospital General Universitari de Castelló, Castellón de la Plana, Comunidad Valenciana, Spain.ORCID 0000-0002-8804-3878
Esther Vicente-EscrigPharmacy, Hospital General Universitari de Castelló, Castellón de la Plana, Comunidad Valenciana, Spain.
Aarón Puplá-BartollPharmacy, Hospital General Universitari de Castelló, Castellón de la Plana, Comunidad Valenciana, Spain.
Julia Bodega AzuaraPharmacy, Hospital General Universitari de Castelló, Castellón de la Plana, Comunidad Valenciana, Spain.
Pablo Pérez-HuertasPharmacy, Hospital Vega Baja, Orihuela, Comunidad Valenciana, Spain.
Raul Ferrando PiqueresPharmacy, Hospital General Universitari de Castelló, Castellón de la Plana, Comunidad Valenciana, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to describe the actions taken to implement a telepharmacy programme with home medication dispensing and informed delivery in an outpatient pharmaceutical care unit of a tertiary hospital, where approximately 5000 patients are treated per year. It also aimed to substantiate the applicability and benefits of the programme through analysing the findings and measuring patient satisfaction.

methodsWe identified the operational, logistical, technological and legal needs, as well as the need for training, information and coordination with the care team and patient associations. A standard operating procedure was developed which described the home dispensing model and the profile of patients eligible for telepharmacy. Care activity was evaluated, between the months of July 2020 and January 2021; and a survey was conducted to measure patient satisfaction based on the Enopex project, a cross-sectional observational study of patients who used telepharmacy services during the COVID-19 lockdown period in Spain.

resultsA total of 2536 medication deliveries were made over 144 working days, with a mean of 18 (standard deviation (SD): 6) deliveries per day, and a total of 2854 dispensings (1.1 drugs per delivery). In total, 197 different types of pharmaceutical formulations were delivered, corresponding to 123 active ingredients. The distance and time avoided during the study period totalled 1 05 624 km and 1 09 452 min (76 days), whereby the median distance and time saved per patient were 66 (interquartile range (IQR):122 km and 90 (IQR:90) minutes, which represents an approximate carbon footprint reduction of 25 kg of CO

conclusionsThe SARS-CoV-2 pandemic (COVID-19) has provided the pharmacy service with an opportunity to develop and implement a telepharmacy programme that benefits patients, which has enabled better organisation of the unit and greater accessibility for patients attending in person. It is a replicable method that is applicable in other pharmacy services with similar characteristics and requirements.

Indexed as

COVID-19TelemedicineCommunicable Disease ControlCross-Sectional StudiesHumansPharmaceutical PreparationsSARS-CoV-2Tertiary Care CentersPharmaceutical PreparationsCOVID-19Health Care Economics and OrganizationsHospital Distribution SystemsMEDICATION SYSTEMS, HOSPITALPHARMACY SERVICE, HOSPITAL

Identifiers

PMID35444000
PMCPMC9986923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.